Stonegate Updates Coverage on Burcon Nutrascience Corporation (TSX: BU) 4Q26

<p class='reportable-dateline'><strong>DALLAS, TX -- JUNE 26, 2026</strong></p><p class='reportable-excerpt'>DALLAS, TX -- June 26th, 2026 --Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU). Burcon has moved from commissioning and into early utilization, with growing customer volume setting up better fixed-cost absorption at Galesburg. The Company completed commissioning and launched commercial production across Peazazz pea protein, Puratein C canola protein, and FavaPro fava protein in FY26. Revenue increased sequentially to $0.83M in 4Q26 from $0.74M in 3Q26, and management indicated current-quarter sales were tracking toward ~50% sequential growth based on April/May activity. Burcon also set a new production record, with daily output roughly 60% above January - March levels. As volume builds, the margin opportunity should come from better utilization, steadier production cadence, and start-up costs moving out of the run-rate cost structure, rather than pricing alone.</p><p>To view the full announcement, including downloadable images, bios, and more, <a href='https://stonegateinc.reportablenews.com/pr/stonegate-updates-coverage-on-burcon-nutrascience-corporation-tsx-bu-4q26' class='reportable-link'>click here</a>.</p><div class='reportable-key-takeaways'><h3>Key Takeaways:</h3><ul><li>Burcon is moving into utilization ramp mode, with 4Q26 revenue of $0.83M and current-quarter sales tracking ~50% higher sequentially.</li><li>Customer traction is broadening, with 30+ purchasing customers and 200+ active projects across pea, canola, and fava applications.</li><li>Funding supports the Galesburg scale-up, with $6.9M completed, $3.0M undrawn, and management targeting $10M of CY26 sales.</li></ul></div><a href='https://stonegateinc.reportablenews.com/pr/stonegate-updates-coverage-on-burcon-nutrascience-corporation-tsx-bu-4q26'><img src='https://cdn.filestackcontent.com/uYWIcGasThKewT90VCRh' class='reportable-featured-image' /><p align='center'><i>Click image above to view full announcement.</i></p></a><hr class='company-boilerplate-rule' style='border: 0; border-top: 1px solid rgba(0,0,0,0.1);'><p class='company-boilerplate'><p><strong>About Stonegate</strong></p><p>Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.</p></p><div class='reportable-contacts'><h3>Contacts:</h3><p class='reportable-contact'>Stonegate Capital Partners<br>(214) 987-4121 <br><a href='mailto:info@stonegateinc.com'>info@stonegateinc.com</a></p></div><p>Source: <a href='https://stonegateinc.reportablenews.com/'>Stonegate, Inc.</a></p><p>Distributed by: <a href='https://reportablenews.com'>Reportable, Inc.</a></p>